Week 48 Typical Outcomes Excellent Responders (Top 25%) Weight loss: 27-31% (59-68 pounds for 220-pound starter) Characteristics: Perfect adherence, implemented all protocols, resistance training consistent, high protein intake maintained Good Responders (Middle 50%) Weight loss: 21-27% (46-59 pounds for 220-pound starter) Characteristics: Good adherence with occasional lapses, followed core protocols, moderate activity Modest Responders (Bottom 25%) Weight loss: 16-21% (35-46 pounds for 220-pound starter) Characteristics: Variable adherence, minimal dietary modification, limited activity, or metabolic resistance factors What Happens After Week 48
Ayudan con el manejo de la diabetes tipo 2, ya que aumentan la secrecin de insulina, suprimen el apetito y ralentizan la digestin
This means it mimics the GLP-1 hormone, which helps lower blood sugar levels and reduce appetite
Get it wrong, and you could compromise the concentration, leading to skewed data and wasted resources
Clinical Trials on GLP-1 Single Agonists Liraglutide: The First GLP-1RA Approved for Adolescent Obesity Liraglutide (Saxenda ) was the first glucagon-like peptide-1 receptor agonist (GLP-1RA) approved for the management of obesity in adolescent populations
(7) E A